These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1100704)

  • 1. [Microorganisms as indicators of the mutagenic activity of chemical compounds and their metabolites].
    Fonshteĭn LM; Shapiro AA; Abilev SK
    Izv Akad Nauk SSSR Biol; 1975; (5):671-81. PubMed ID: 1100704
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutagenic selectivity for the RNA-forming genes in relation to the carcinogenicity of alkylating agents and polycyclic aromatics.
    Fahmy OG; Fahmy MJ
    Cancer Res; 1972 Mar; 32(3):550-7. PubMed ID: 4110704
    [No Abstract]   [Full Text] [Related]  

  • 3. [New developments in the area of carcinogenic compounds and their pharmacodynamics (continuation and conclusion)].
    Dannenberg H
    Dtsch Med J; 1967 Jun; 18(12):386-90 concl. PubMed ID: 5608293
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene elimination in carcinogenesis: reinterpretation of the somatic mutation theory.
    Fahmy OG; Fahmy MJ
    Cancer Res; 1970 Jan; 30(1):195-205. PubMed ID: 5458960
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mutagenic equivalence between ionizing radiation and radiomimetic substances].
    Gatti GL; Toffoli F
    Boll Chim Farm; 1978 Feb; 117(2):64-70. PubMed ID: 743361
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of rapid test systems for detecting the carcinogenic and mutagenic activity of chemical compounds].
    Zakharov IA; Kasinova GV; Koval'tsova SV; Marfin SV
    Izv Akad Nauk SSSR Biol; 1984; (5):729-45. PubMed ID: 6501695
    [No Abstract]   [Full Text] [Related]  

  • 7. Mutagenic alkylating agents as growth inhibitors and carcinogens.
    Koller PC
    Mutat Res; 1969; 8(1):199-206. PubMed ID: 5796941
    [No Abstract]   [Full Text] [Related]  

  • 8. Cycasin and its mutagenic metabolites.
    Morgan RW; Hoffmann GR
    Mutat Res; 1983 Jan; 114(1):19-58. PubMed ID: 6338356
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemical mutagenesis at the molecular level].
    Otsuji N
    Tanpakushitsu Kakusan Koso; 1972 Jun; 17(6):414-22. PubMed ID: 4561589
    [No Abstract]   [Full Text] [Related]  

  • 10. [Induction of cytoplasmatic and genic respiration defective mutants by the carcinogen nitrosamide l-nitroso-imidazolidone-2 in Saccharomyces cerevisiae].
    Schwaier R
    Arzneimittelforschung; 1969 Jul; 19(7):1050-2. PubMed ID: 5394506
    [No Abstract]   [Full Text] [Related]  

  • 11. [The mutagenic effect of several alkylating substances on Aspergillus nidulans].
    Kovalenko SP; Lavrenchuk IM
    Mikrobiol Zh; 1970; 32(1):35-9. PubMed ID: 5517360
    [No Abstract]   [Full Text] [Related]  

  • 12. Mice over-expressing human O6 alkylguanine-DNA alkyltransferase selectively reduce O6 methylguanine mediated carcinogenic mutations to threshold levels after N-methyl-N-nitrosourea.
    Allay E; Veigl M; Gerson SL
    Oncogene; 1999 Jun; 18(25):3783-7. PubMed ID: 10391687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial and mammalian mutagenicity tests: validation and comparative studies on 180 chemicals.
    Bartsch H; Malaveille C; Camus AM; Martel-Planche G; Brun G; Hautefeuille A; Sabadie N; Barbin A; Kuroki T; Drevon C; Piccoli C; Montesano R
    IARC Sci Publ; 1980; (27):179-241. PubMed ID: 7002778
    [No Abstract]   [Full Text] [Related]  

  • 14. Oncogenic transformation and mutation of C3H/10T 1/2 clone 8 mouse embryo fibroblasts by alkylating agents.
    Peterson AR; Landolph JR; Peterson H; Spears CP; Heidelberger C
    Cancer Res; 1981 Aug; 41(8):3095-9. PubMed ID: 7248967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of mutations induced by chemical carcinogens in mammalian cells. II. The use of recombinant DNA vectors.
    Basic-Zaninovic T; Palombo F; Calcagnile AS; Dogliotti E
    Ann Ist Super Sanita; 1994; 30(2):191-9. PubMed ID: 7832410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational response at the splenic T-lymphocyte hprt locus in mice treated as neonates: contrasting effects of the carcinogens N-ethyl-N-nitrosourea, dimethylnitrosamine, and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Dass SB; Heflich RH; Casciano DA
    Environ Mol Mutagen; 1998; 31(3):243-7. PubMed ID: 9585262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some aspects of teratogenesis and mutagenesis in mammalian embryos.
    Bass R; Bochert G; Merker HJ; Neubert D
    J Toxicol Environ Health; 1977 Jul; 2(6):1353-74. PubMed ID: 328922
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition and enhancement of oncogenic cell transformation in C3H 10T 1/2 CL8 cells.
    Nesnow S; Garland H; Curtis G
    Carcinog Compr Surv; 1985; 10():225-34. PubMed ID: 4064005
    [No Abstract]   [Full Text] [Related]  

  • 19. Mutagenicity of cycasin aglycone (methylazoxymethanol), a naturally occurring carcinogen.
    Smith DW
    Science; 1966 May; 152(3726):1273-4. PubMed ID: 5327886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of DNA damage in chemical carcinogenesis.
    Rajewsky MF
    IARC Sci Publ; 1980; (27):41-54. PubMed ID: 7002782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.